Illinois legislators have introduced a bill to legalize psychedelic drugs, including psilocybin, the main psychoactive compound in magic mushrooms, for therapeutic purposes. The bill, called the Entheogen Compassionate Use and Research (CURE) Act, was introduced Wednesday by Democratic State Rep. LaSean Ford.
The bill, which Ford announced on the first day of a new legislative session in Illinois, would create a regulated psychedelic therapy program overseen by an advisory board.measures designated as House Bill 1 (HB1) also removes criminal penalties for personal use of psilocybin. This is a provision Ford said in a statement to protect patients and healthcare providers. Ford said that while existing criminal bans on drugs are rarely enforced, “the formal elimination of drugs prevents patients from becoming criminals simply in their quest for health, healing and wellness.” I can do it,” he said.
“We are aiming for a growing body of valid scientific evidence, including information from the FDA, showing that psychedelic therapy is not only safe, but highly effective, especially for the most difficult patients who have failed other treatments. I am doing it.” Ford said In a legal press release. “At the same time, we are hearing from patients and providers that Illinoisans should be able to access these exciting new treatment options.”
HB 1 Legalizes Psychedelic Therapy in Illinois
Under this law, adults over the age of 18 are permitted to seek supervised psychedelic therapy by a trained facilitator. Psychedelic compounds used in the program must be manufactured and tested in a licensed facility. Ford stressed that while the bill would legalize the possession of hallucinogens, it would not permit the commercial sale of entheogenic compounds of any kind.
“I want to be clear that this is a health measure. My proposal is not to allow the retail sale of psilocybin outside of regulated treatment settings, and that medicines purchased for treatment in service centers should be under the supervision of a physician. “Only licensed facilitators are strictly regulated and can be used at licensed healing centers, approved medical facilities, hospices, or pre-approved facilities.” It is permissible to provide treatment at the patient’s residence.”
Ford said in a statement that growing research on exogenous plants and fungi, such as psilocybin, suggests that these drugs may be used to treat a wide range of mental health conditions, including depression, post-traumatic stress disorder, and anxiety. It has been shown that it may be treatable, he said. Hallucinogens are also effective treatments for neurological conditions such as cluster headaches, migraines, cancer, and phantom limbs. I have been assigned a status.
Bill takes another step in psychedelic policy reform efforts
Although the bill focuses on naturally occurring psychedelic compounds, Joshua Kappel, founding partner of the cannabis and psychedelics law firm Vicente Cederberg LLP, said the bill’s provisions would include entheogens traditionally grown or harvested. This difference marks an important evolution in psychedelic policy reform efforts, with two states so far legalizing the therapeutic use of psilocybin.
“We are building Colorado and Oregon in very thoughtful and progressive ways, including allowing synthetic varieties of natural medicines permitted in Colorado,” Kappel said in an email. writing. high times“This is an important development in terms of sustainability.”
House Bill 1 already has the support of a broad coalition of medical and mental health professionals, researchers, patients, and grassroots psychedelic reform activists.Many people work together to form Enteo IL Leading psychedelic policy reform efforts in Illinois.
Gene Lacy, executive director of the new group, said in a statement, “The drive for legal access to enteogenic medicines is growing at the federal level, as well as at the state level, such as Oregon and Colorado. ‘ said. “This law ensures that Illinois is a leader in developing the infrastructure needed for this work.”